Literature DB >> 9973020

A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.

M A Stevens1, P A McCullough, K J Tobin, J P Speck, D C Westveer, D A Guido-Allen, G C Timmis, W W O'Neill.   

Abstract

OBJECTIVES: This study was done to test the hypothesis that a forced diuresis with maintenance of intravascular volume after contrast exposure would reduce the rate of contrast-induced renal injury.
BACKGROUND: We have previously shown a graded relationship with the degree of postprocedure renal failure and the probability of in-hospital death in patients undergoing percutaneous coronary intervention. Earlier studies of singular prevention strategies (atrial natriuretic factor, loop diuretics, dopamine, mannitol) have shown no clear benefit across a spectrum of patients at risk.
METHODS: A prospective, randomized, controlled, single-blind trial was conducted where 98 participants were randomized to forced diuresis with intravenous crystalloid, furosemide, mannitol (if pulmonary capillary wedge pressure <20 mm Hg), and low-dose dopamine (n = 43) versus intravenous crystalloid and matching placebos (n = 55).
RESULTS: The groups were similar with respect to baseline serum creatinine (2.44+/-0.80 and 2.55+/-0.91 mg/dl), age, weight, diabetic status, left ventricular function, degree of prehydration, contrast volume and ionicity, and extent of peripheral vascular disease. The forced diuresis resulted in higher urine flow rate (163.26+/-54.47 vs. 122.57+/-54.27 ml/h) over the 24 h after contrast exposure (p = 0.001). Two participants in the experimental arm versus five in the control arm required dialysis, with all seven cases having measured flow rates <145 ml/h in the 24 h after the procedure. The mean individual change in serum creatinine at 48 h, the primary end point, was 0.48+/-0.86 versus 0.51+/-0.87, in the experimental and control arms, respectively, p = 0.87. There were no differences in the rates of renal failure across six definitions of renal failure by intent-to-treat analysis. However, in all participants combined, the rise in serum creatinine was related to the degree of induced diuresis after controlling for baseline renal function, r = -0.36, p = 0.005. The rates of renal failure in those with urine flow rates greater than 150 ml/h in the postprocedure period were significantly lower, 8/37 (21.6%) versus 28/61 (45.9%), p = 0.03.
CONCLUSIONS: Forced diuresis with intravenous crystalloid, furosemide, and mannitol if hemodynamics permit, beginning at the start of angiography provides a modest benefit against contrast-induced nephropathy provided a high urine flow rate can be achieved.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973020     DOI: 10.1016/s0735-1097(98)00574-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  40 in total

1.  Urine protein as a rapid screen for renal function in the ED: can it replace serum creatinine in selected patients?

Authors:  Jonathan Glauser; Aaron Montgomery
Journal:  Emerg Radiol       Date:  2004-05-05

Review 2.  Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist.

Authors:  Jeffrey J Pasternak; Eric E Williamson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

Review 3.  Contrast nephropathy.

Authors:  Shereif H Rezkalla
Journal:  Clin Med Res       Date:  2003-10

4.  Contrast-induced nephropathy: what we know, what we think we know, and what we don't know.

Authors:  Brian Funaki
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

Review 5.  Contrast-associated acute kidney injury.

Authors:  Matthew Everson; Kittiya Sukcharoen; Quentin Milner
Journal:  BJA Educ       Date:  2020-10-03

6.  Diagnosing and treating contrast-induced acute kidney injury in 2017.

Authors:  Vikram Raje; George Feldman; Ion S Jovin
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

7.  Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.

Authors:  Alper O Onbasili; Yavuz Yeniceriglu; Pinar Agaoglu; Aslihan Karul; Tarkan Tekten; Harun Akar; Guzel Discigil
Journal:  Heart       Date:  2006-10-25       Impact factor: 5.994

Review 8.  [Contrast medium-induced acute kidney injury-Consensus paper of the working group "Heart and Kidney" of the German Cardiac Society and the German Society of Nephrology].

Authors:  J Latus; V Schwenger; G Schlieper; H Reinecke; J Hoyer; P B Persson; B A Remppis; F Mahfoud
Journal:  Internist (Berl)       Date:  2020-12-21       Impact factor: 0.743

Review 9.  Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM.

Authors:  Michael Joannidis; Wilfred Druml; Lui G Forni; A B Johan Groeneveld; Patrick Honore; Heleen M Oudemans-van Straaten; Claudio Ronco; Marie R C Schetz; Arend Jan Woittiez
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

10.  Non-contrast 3D time-of-flight magnetic resonance angiography for visualization of intracranial aneurysms in patients with absolute contraindications to CT or MRI contrast.

Authors:  Vijay Yanamadala; Sameer A Sheth; Brian P Walcott; Bradley R Buchbinder; Deidre Buckley; Christopher S Ogilvy
Journal:  J Clin Neurosci       Date:  2013-05-16       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.